menu
    • menu

    Company profile for Cipla

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients. Since inception in 1935, caring has been at the core of everything we do at Cipla. For patients, caring is a promise that we...
    Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients. Since inception in 1935, caring has been at the core of everything we do at Cipla. For patients, caring is a promise that we will do whatever it takes to ensure they have continued access to the highest quality medicines at affordable prices; whether a disease affects millions or just a few hundreds.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ciplaindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumba...
    Telephone
    Telephone
    +91 22 23082891 / 23095521
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cipla.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI Japan

    Not Confirmed

    envelop Contact Supplier

    CPhI Japan

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    This week, SpeakPharma interviews Pete Werth III, the new president of ChemWerth, a company that has been at the forefront of the generic pharmaceutical industry for over four decades. He shares his vision for ChemWerth, which includes his commitment to strengthening global manufacturing relationships, and enhancing supply chain resilience. Additionally, he highlights the key aspects of a successful drug master file (DMF). HIGHLIGHTS// Pete Werth III, the new president of ChemWerth/ vision for ChemWerth/ commitment to strengthening global manufacturing relationships/ key aspects of a successful drug master file Your father, Peter J. Werth, is recognized as one of the founders of the generic pharmaceutical industry, having built ChemWerth from the ground up over four decades ago. How do you view his legacy? As you take the helm, what key lessons or principles from his leadership do you intend to carry forward? My father, Peter J. Werth, is a true pioneer in the generic pharmaceutical industry. Over his 42‐year tenure, he not only built ChemWerth from a humble garage startup into a global leader in generic API development but also established standards that many in our industry now take for granted. Under his leadership, we filed our very first DMF in 1987 and have since achieved more than 500 DMF filings. With an average review cycle of just 0.79, we have been far outperforming the industry average of 2.5 cycles. His focus on quality, regulatory excellence, and a relentless commitment to customers’ success set the foundation for our reputation as a trusted supplier of over 500 APIs sourced from more than 30 cGMP-certified facilities worldwide. Equally inspiring is his dedication to nurture long-term, mutually beneficial relationships with manufacturing partners across the US, Europe, India, and China, as well as his passion for giving back to the community through philanthropic initiatives. As I take the helm, I intend to build on his guiding principles — sustaining our high standards of quality and compliance while pursuing innovation in regulatory strategy, diversifying our supply chain, and embracing new technologies and approaches to remain competitive in an evolving market. I will also strive to continue his legacy of mentorship, ensuring that our company culture remains rooted in integrity and diligence, with an unyielding focus on making safe, affordable medicines available worldwide. HIGHLIGHTS// trusted supplier of over 500 APIs/ 30 cGMP-certified facilities worldwide/ embracing new technologies and approaches to remain competitive What are your top priorities as the new president of ChemWerth? How do you plan to strengthen and expand relationships with manufacturers worldwide? My immediate priorities as the new president are twofold: to enhance the value we deliver to our customers and, to deepen our relationships with our manufacturing partners worldwide. We will further diversify our supply chain and broaden our product portfolio. Our expansion plans include upgrading equipment, and hiring additional highly skilled scientists, engineers, and GMP auditors. We will also leverage our proprietary product selection and regulatory submission processes. These processes help us get the regulatory filing right the first time, and allows us to be approved 44 percent faster than the industry average. This helps our customers gain a competitive edge in the market. In essence, by strengthening operational excellence and expanding our global network, we intend to continue the company’s long-standing commitment to customer success and process innovation. We plan to reinforce our long-standing relationships with our manufacturers — especially those in strategic markets like China and India — by helping our partners meet the highest standards of regulatory compliance and current good manufacturing practice (cGMP) quality. This balanced approach of strengthening existing partnerships while pioneering new ones is key to maintaining and growing our competitive edge. HIGHLIGHTS// diversify our supply chain and broaden our product portfolio/ commitment to customer success and process innovation/ filings approved 44 percent faster than the industry average When ChemWerth last spoke to PharmaCompass, there was a mention of investing millions of dollars in expanding manufacturing partnerships in China and India. Can you elaborate on the success of these partnerships, and how have they contributed to ChemWerth’s overall growth? Our strategic, multimillion-dollar investments in manufacturing partnerships are a cornerstone of our growth strategy. Over the past few years, these joint ventures have proven their worth by diversifying our supply base and mitigating the risk of global supply chain disruptions — a lesson that became all too clear during the Covid-19 pandemic. These investments are already paying dividends. They help us support manufacturers producing steroids, hormones, veterinary products, and large-volume APIs, while also accelerating the development of small-molecule inhibitors and new generic APIs. We have ensured that our partners are equipped with the latest equipment and trained personnel to meet cGMP standards. By partnering with facilities in these markets, we now have access to state-of-the-art production capabilities that enable us to produce a wider range of APIs at competitive costs. The success of these partnerships is evident in our ability to consistently file DMFs rapidly — often on the first cycle — and deliver affordable, high-quality medicines to patients worldwide. This supports our clients’ growth trajectory and has helped us expand into new markets. This strategy has reinforced our global footprint — supporting our presence in 38 countries with over 100 products — and positioned us well to capitalize on a global generic drug market projected to grow at a compounded annual growth rate of 5.4 percent from 2022 to 2030, to reach a size of US$ 671 billion by 2030. HIGHLIGHTS// strategic multimillion-dollar investments/ support manufacturers producing steroid, hormone, veterinary products/ development of small-molecule inhibitors and new generic APIs/ ensured partners are equipped with the latest equipment and trained personnel ChemWerth has an impressive track record, and an over 40-year relationship with the US Food and Drug Administration (FDA). What are the key aspects of a successful DMF? Are there specific challenges manufacturers face in preparing DMFs, and how does ChemWerth help them overcome these hurdles? ChemWerth’s record of filing over 500 DMFs in 38 countries reflects our commitment to excellence in regulatory compliance and quality management. A successful DMF is built on comprehensive documentation that rigorously follows cGMP guidelines, robust analytical validation, and detailed tracking of every step. Every DMF we file meticulously details the entire manufacturing process — from raw material acquisition to final batch production. This comprehensive approach ensures that our submissions meet the rigorous quality, safety, and efficacy standards expected by the FDA. Our team stays continuously updated on the evolving guidelines and protocols, which allows us to file DMFs that align with current FDA practices. We recognize that many manufacturers face challenges such as complex regulatory requirements, lengthy review cycles, and the need for precise coordination between various production stages. ChemWerth helps them overcome these hurdles by offering end-to-end regulatory support, detailed internal audits, and continuous training on cGMP and FDA requirements. Our efficiency is a critical competitive advantage. By receiving approvals 44 percent faster than the industry average, we help our customers get their products to market faster, resulting in larger market share and increased profits. HIGHLIGHTS// over 500 DMFs in 38 countries/ robust analytical validation/ end-to-end regulatory support What is your vision for ChemWerth over the next few years? How do you plan to navigate the challenges and opportunities in the generic pharmaceutical industry? I plan to continue to add value for our customers, and look for innovative ways to compete in today’s generic pharmaceutical landscape. At ChemWerth, our vision for the future is rooted in both our proud legacy and our relentless drive for innovation. We will further diversify our supply chain and expand our product portfolio. We have begun leveraging our expertise to supply APIs for biosimilars and new drug applications (NDAs), while maintaining our reputation for rapid regulatory approvals. With unwavering determination, we uphold our “First to Quality. Fast to Market.” approach — delivering high-quality APIs to customers worldwide while leveraging our expertise to give them a competitive edge in their markets. HIGHLIGHTS// supply APIs for biosimilars and NDAs/ give customers a competitive edge in their markets 

    Impressions: 810

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage

    Radio Compass
    12 Mar 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

    Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

    This week, we delve into molecular glue degraders (MGDs), one of the most promising frontiers in drug development. MGDs address a vast number of previously “undruggable” disease-causing proteins.Unlike traditional small molecule drugs that require specific binding pockets, MGDs function by enhancing protein-protein interactions. MGDs selectively target disease-causing proteins and an enzyme known as E3 ubiquitin ligase. By creating a binding interface between the two, MGDs  destroy the target proteins.Another kind of degraders are proteolysis targeting chimeras (PROTACs) that use a bifunctional approach — one binds the target proteins, and the other binds to an E3 ligases together. These degraders induce the degradation of specific proteins by using the cell’s natural ubiquitin-proteasome system (a process in cells where damaged or unneeded proteins are tagged by a small molecule called ubiquitin and then broken down by a structure called the proteasome so that cells stay healthy and function properly).MGDs constitute a rapidly growing market, where both the targeted protein degradation technologies and investment in research and development are witnessing growth.Currently, the most recognized molecular glues are the immunomodulatory imide drugs (IMiDs), such as thalidomide, lenalidomide and pomalidomide, which have been around for some time. According to GlobalData, lenalidomide generated over US$ 6 billion in sales in 2023, thereby demonstrating the commercial viability of this therapeutic approach.Lilly, AbbVie ink billion-dollar MGD deals; Biogen partners Neomorph; Pfizer, Triana ink collaborationThe MGD space has witnessed extraordinary deal-making activity over the recent months, with major pharmaceutical companies committing billions of dollars to secure access to novel MGD platforms and pipelines. This surge in investment reflects the industry’s growing confidence in the therapeutic potential of MGDs to address previously undruggable targets.This year has already seen two landmark deals. In February, Magnet Biomedicine entered into a collaboration and license agreement with Eli Lilly worth up to US$ 1.29 billion to discover and develop novel MGDs. This partnership leverages Magnet’s TrueGlue discovery platform and approach with Lilly’s expertise in the development of small molecule therapeutics. In January, AbbVie crafted a US$ 1.64 billion deal with molecular glue biotech Neomorph, combining AbbVie’s oncology and immunology drug development capabilities with Neomorph's leading molecular glue discovery platform.While oncology remains the primary focus, these collaborations are increasingly expanding into neurodegenerative diseases, immunological disorders, and other therapeutic areas. For instance, in October, Biogen and Neomorph announced a multi-target research collaboration to discover and develop MGDs for Alzheimer’s, rare neurological, and immunological diseases, potentially worth up to US$ 1.45 billion.October also saw Novartis sign a potential US$ 2.25 billion deal with Monte Rosa Therapeutics. The deal gives Novartis exclusive worldwide rights to develop, manufacture and commercialize multiple MGDs (including MRT-6160) for undruggable targets, including in the areas of immunology and inflammation, metabolism, and genetic diseases.Earlier in October, Triana Biomedicines and Pfizer entered into a research collaboration to discover novel MGDs for multiple targets across several disease areas, including oncology, with a total potential value of up to US$ 1.55 billion.And in August 2024, SEED Therapeutics entered into a strategic research collaboration with Eisai to discover and develop novel MGDs for neurodegenerative and oncological indications, potentially worth up to US$ 1.5 billion.BMS leads with three MGDs in late-stage trials; Monte Rosa’s MRT-2359 targets solid tumorsBristol Myers Squibb has established itself as a leader in the clinical development of MGDs with three products in late-stage development. These include a next-gen MGD mezigdomide (CC-92480), which is currently in phase 3 trials in combination with carfilzomib and dexamethasone for relapsed/refractory multiple myeloma. Another candidate is golcadomide, which is in late-stage clinical trials for high-risk first-line large B-cell lymphoma. And the third MGD in BMS’ portfolio is iberdomide, which has reached phase 3 development for multiple myeloma.Monte Rosa Therapeutics has made significant progress with MRT-2359, an investigational MGD that is currently in phase 1/2 clinical trials for the treatment of patients with MYC-driven solid tumors, including non-small cell lung cancer, small cell lung cancer, and high-grade neuroendocrine cancer. Myelocytomatosis or MYC is a gene which causes various solid tumors when overactive.MRT-2359 represents an important advancement in extending the molecular glue approach beyond hematological malignancies to solid tumors, which have historically proven more challenging to address with protein degradation strategies.Other significant early-stage candidates are Nested Therapeutics’ NST-628 and Plexium's PLX-4545. NST-628 relies on a novel mechanism of action in its category of RAS-MAPK inhibitors, and overcomes some traditional limitations in the treatment of cancers.PLX-4545 is Plexium’s first small molecule degrader program to enter clinical development. This potent and selective MGD of a classically undruggable transcription factor, also known as Helios (IKZF2), explores treating solid tumors. Transcription factors are proteins that regulate gene expression by binding to specific DNA sequences.Boehringer’s KRAS degrader advances PROTACs approach; Arvinas tests ARV-102 for neurodegenerative diseasesLike MGDs, PROTACs are also witnessing advancements in both R&D and dealmaking. For instance, BridGene Biosciences recently expanded its strategic collaboration with Galapagos to develop a selective oral SMARCA2 PROTAC in precision oncology. The SMARCA2 gene provides instructions for making one piece (subunit) of a group of similar protein complexes known as SWI/SNF complexes.In the clinical arena, Prelude Therapeutics announced a collaboration with Merck to evaluate PRT3789 in combination with Keytruda (pembrolizumab) in patients with SMARCA4-mutated cancers. PRT3789 is a potent and highly selective, first-in-class SMARCA2 degrader.On the molecular front, ACBI3, a novel pan-KRAS degrader developed through a collaboration between the University of Dundee and Boehringer Ingelheim, addresses a critical gap in cancer therapy by targeting 13 out of 17 prevalent KRAS mutants. KRAS mutation is a change in the KRAS gene, a common gene that can cause cancer. ACBI3’s development is a potential breakthrough for millions of cancer patients with KRAS-driven tumors.Vepdegestrant (ARV-471), a collaborative effort between Arvinas and Pfizer, remains the most advanced PROTAC candidate to date and has met its primary endpoint in a late-stage study in breast cancer patients with estrogen receptor 1 mutations.  Similarly, Arvinas’ ARV-102 became the first PROTAC to be tested in humans for neurodegenerative diseases, marking a significant milestone in addressing brain-related disorders.Our viewMGDs offer a new, and groundbreaking approach to treating cancers and various other diseases, thereby attracting substantial investments by major pharmaceutical companies. As clinical trials show encouraging results, we expect investments in the MGDs space to increase even further. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 488

    https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs

    #Phispers by PHARMACOMPASS
    27 Mar 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Cipla CEO: Tariffs Should Not Dictate Indian Pharma Business
    Cipla CEO: Tariffs Should Not Dictate Indian Pharma Business

    03 Mar 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/tariffs-should-not-dictate-how-indian-drugmakers-do-business-cipla-ceo-says/articleshow/118633708.cms

    ECONOMICTIMES
    03 Mar 2025
    Share Share
    Cipla Beats Q3 Profit View as India Offsets Weak U.S. Sales
    Cipla Beats Q3 Profit View as India Offsets Weak U.S. Sales

    28 Jan 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/indias-cipla-beats-q3-profit-view-strong-demand-north-america-2025-01-28/

    REUTERS
    28 Jan 2025
    Share Share
    Cipla Goa facility receives form 483 with 1 observation
    Cipla Goa facility receives form 483 with 1 observation

    21 Jan 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/markets/stocks/news/cipla-shares-in-focus-after-goa-facility-receives-form-483-with-one-observation-from-usfda/articleshow/117413516.cms?from=mdr

    ECONOMICTIMES
    21 Jan 2025
    Share Share
    Briefs: Cipla and IOL Chemicals and Pharmaceuticals
    Briefs: Cipla and IOL Chemicals and Pharmaceuticals

    21 Jan 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/briefs-cipla-and-iol-chemicals-and-pharmaceuticals-16690

    INDPHARMAPOST
    21 Jan 2025
    Share Share
    Cipla rolls out mobile application for asthma screening
    Cipla rolls out mobile application for asthma screening

    06 Jan 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-rolls-out-mobile-application-for-asthma-screening/articleshow/116985856.cms

    ECONOMICTIMES
    06 Jan 2025
    Share Share
    Cipla`s Generics Phytonadione Receives Approval in US
    Cipla`s Generics Phytonadione Receives Approval in US

    03 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214966

    FDA
    03 Jan 2025
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Amlodipine Besylate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BePharma
    Not Confirmed
    arrow

    Amlodipine Besylate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-03-17

    Pay. Date : 2017-03-06

    DMF Number : 17032

    Submission : 2003-12-17

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2015-140 - Rev 00

    Issue Date : 2020-09-16

    Type : Chemical

    Substance Number : 1491

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 221MF10131

    Registrant's Address : Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013, INDIA

    Initial Date of Registration : 2009-06-30

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-20

    Valid Till : 2025-08-08

    Written Confirmation Number : WC-0113

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7561

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (35kg/35kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Hiple Co., Ltd.

    Registration Date : 2014-03-10

    Registration Number : 20101029-130-H-18-03(2)

    Manufacturer Name : Cipla Limited

    Manufacturer Address : Virgonagar Post, Old Madras Road, Bangalore - 560 049, India.

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Celecoxib

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BePharma
    Not Confirmed
    arrow

    Celecoxib

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-09-28

    Pay. Date : 2013-09-20

    DMF Number : 16671

    Submission : 2003-06-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2014-186 - Rev 01

    Issue Date : 2023-05-30

    Type : Chemical

    Substance Number : 2591

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 230MF10110

    Registrant's Address : Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013, INDIA

    Initial Date of Registration : 2018-08-20

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0144nA2

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7533

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Hanlim Pharmaceutical Co., Ltd.

    Registration Date : 2019-04-12

    Registration Number : 20190104-209-J-128(1)

    Manufacturer Name : Cipla Limited

    Manufacturer Address : D-7, MIDC, Industrial Area, Kurkumbh, Taluka Daund, Pune 413 802, Maharashtra State, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Etoposide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BePharma
    Not Confirmed
    arrow

    Etoposide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 10642

    Submission : 1993-12-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2007-061 - Rev 06

    Issue Date : 2024-09-17

    Type : Chemical

    Substance Number : 823

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 222MF10214

    Registrant's Address : Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013, INDIA

    Initial Date of Registration : 2010-08-05

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-20

    Valid Till : 2025-08-08

    Written Confirmation Number : WC-0113

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7514

    Start Marketing Date : 2018-07-13

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (4kg/4kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Risedronate Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BePharma
    Not Confirmed
    arrow

    Risedronate Sodium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 20162

    Submission : 2007-03-16

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2014-130 - Rev 00

    Issue Date : 2020-04-28

    Type : Chemical

    Substance Number : 2572

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 223MF10141

    Registrant's Address : Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013, INDIA

    Initial Date of Registration : 2011-09-07

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0144nA2

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7653

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Alendronate Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BePharma
    Not Confirmed
    arrow

    Alendronate Sodium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2019-12-15

    Pay. Date : 2019-12-11

    DMF Number : 14334

    Submission : 1999-08-06

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2005-126 - Rev 04

    Issue Date : 2018-08-29

    Type : Chemical

    Substance Number : 1564

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0144nA2

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7525

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Cetirizine Dihydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BePharma
    Not Confirmed
    arrow

    Cetirizine Dihydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2016-03-25

    Pay. Date : 2016-03-08

    DMF Number : 15145

    Submission : 2000-11-17

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2000-081 - Rev 07

    Issue Date : 2019-08-09

    Type : Chemical

    Substance Number : 1084

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-07-05

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0143n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7528

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Hanol Biopharma Co., Ltd.

    Registration Date : 2011-11-18

    Registration Number : 20080829-40-C-239-12(6)

    Manufacturer Name : Cipla Limited

    Manufacturer Address : A-33& A-37/2/2, MIDC, Patalganga-410 220, District:Raigad, Maharashtra State

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Felodipine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BePharma
    Not Confirmed
    arrow

    Felodipine

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 11449

    Submission : 1995-04-17

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1999-022 - Rev 05

    Issue Date : 2023-04-06

    Type : Chemical

    Substance Number : 1013

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-20

    Valid Till : 2025-08-08

    Written Confirmation Number : WC-0113

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7519

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (40kg/40kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : KMS Pharmaceutical Co., Ltd.

    Registration Date : 2011-06-30

    Registration Number : 20050831-69-B-181-03(2)

    Manufacturer Name : Cipla Limited

    Manufacturer Address : Virgonagar, Old Madras Road, Bangalore 560 049, India (Mumbai Central Mumbai 400 008 India)

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Fluticasone Propionate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BePharma
    Not Confirmed
    arrow

    Fluticasone Propionate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-08-25

    Pay. Date : 2014-08-14

    DMF Number : 15774

    Submission : 2001-12-19

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2020-075 - Rev 02

    Issue Date : 2024-10-25

    Type : Chemical

    Substance Number : 1750

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0144nA2

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7531

    Start Marketing Date : 1999-06-17

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Omeprazole

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BePharma
    Not Confirmed
    arrow

    Omeprazole

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 12827

    Submission : 1998-01-21

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1997-122 - Rev 05

    Issue Date : 2015-03-19

    Type : Chemical

    Substance Number : 942

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-20

    Valid Till : 2025-08-08

    Written Confirmation Number : WC-0113

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7520

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (30kg/30kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Ondansetron Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BePharma
    Not Confirmed
    arrow

    Ondansetron Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 15724

    Submission : 2001-11-15

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2006-279 - Rev 04

    Issue Date : 2025-02-03

    Type : Chemical

    Substance Number : 2016

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0144nA2

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7540

    Start Marketing Date : 2018-11-15

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    16a-bromoepiandrosterone

    India
    BePharma
    Not Confirmed
    arrow

    02

    Abacavir Sulfate Usp

    India
    BePharma
    Not Confirmed
    arrow

    03

    Abiraterone Acetate

    India
    BePharma
    Not Confirmed
    arrow

    04

    Abiraterone Acetate Usp

    India
    BePharma
    Not Confirmed
    arrow

    05

    Acalabrutinib

    India
    BePharma
    Not Confirmed
    arrow

    06

    Acalabrutinib Maleate

    India
    BePharma
    Not Confirmed
    arrow

    07

    Acyclovir

    India
    BePharma
    Not Confirmed
    arrow

    08

    Adefovir Dipivoxil

    India
    BePharma
    Not Confirmed
    arrow

    09

    Albendazole (b) Usp

    India
    BePharma
    Not Confirmed
    arrow

    10

    Albendazole Usp

    India
    BePharma
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    All Excipients

    read-more
    read-more

    01

    Dodecyl Maltoside

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BePharma
    Not Confirmed
    arrow

    Dodecyl Maltoside

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 40558

    Submission : 2024-10-17

    Status : Active

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Salcaprozate Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BePharma
    Not Confirmed
    arrow

    Salcaprozate Sodium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 39618

    Submission : 2024-10-10

    Status : Active

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Cipla Limited and get a quotation

    Cipla Limited is a supplier offers 305 products (APIs, Excipients or Intermediates).

    Find a price of Amlodipine Besylate bulk with DMF, CEP, JDMF, WC offered by Cipla Limited

    Find a price of Celecoxib bulk with DMF, CEP, JDMF, WC offered by Cipla Limited

    Find a price of Etoposide bulk with DMF, CEP, JDMF, WC offered by Cipla Limited

    Find a price of Risedronate Sodium bulk with DMF, CEP, JDMF, WC offered by Cipla Limited

    Find a price of Abacavir Sulfate bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Alendronate Sodium bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Anastrozole bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Bicalutamide bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Budesonide bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Cetirizine Dihydrochloride bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Efinaconazole bulk with DMF, JDMF, WC offered by Cipla Limited

    Find a price of Escitalopram Oxalate bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Esomeprazole Magnesium bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Exemestane bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Felodipine bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Finasteride bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Fluticasone Propionate bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Formoterol Fumarate bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Gefitinib bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Granisetron Hydrochloride bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Imatinib Mesylate bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Lamivudine bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Leflunomide bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Letrozole bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Meloxicam bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Mometasone Furoate bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Omeprazole bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Ondansetron Hydrochloride bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Oseltamivir Phosphate bulk with DMF, JDMF, WC offered by Cipla Limited

    Find a price of Pantoprazole Sodium bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Pirfenidone bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Pramipexole Dihydrochloride bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Praziquantel bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Ramipril bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Risperidone bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Rivastigmine Tartrate bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Salbutamol Sulphate bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Solifenacin Succinate bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Terbinafine Hydrochloride bulk with DMF, CEP, WC offered by Cipla Limited

    Find a price of Abiraterone Acetate bulk with JDMF, WC offered by Cipla Limited

    Find a price of Beclomethasone Dipropionate bulk with CEP, WC offered by Cipla Limited

    Find a price of Carvedilol bulk with CEP, WC offered by Cipla Limited

    Find a price of Citalopram Hydrobromide bulk with CEP, WC offered by Cipla Limited

    Find a price of Cyproterone Acetate bulk with CEP, WC offered by Cipla Limited

    Find a price of Desloratadine bulk with CEP, WC offered by Cipla Limited

    Find a price of Esomeprazole Magnesium bulk with DMF, CEP offered by Cipla Limited

    Find a price of Fluconazole bulk with CEP, WC offered by Cipla Limited

    Find a price of Lamotrigine bulk with DMF, CEP offered by Cipla Limited

    Find a price of Nevirapine bulk with DMF, WC offered by Cipla Limited

    Find a price of Omeprazole Sodium bulk with CEP, WC offered by Cipla Limited

    Find a price of Rizatriptan Benzoate bulk with CEP, WC offered by Cipla Limited

    Find a price of Salmeterol Xinafoate bulk with CEP, WC offered by Cipla Limited

    Find a price of Tamsulosin bulk with CEP, WC offered by Cipla Limited

    Find a price of Trimetazidine Hydrochloride bulk with DMF, CEP offered by Cipla Limited

    Find a price of Venlafaxine Hydrochloride bulk with CEP, WC offered by Cipla Limited

    Find a price of Ambrisentan bulk with DMF, WC offered by Cipla Limited

    Find a price of Anagrelide Hydrochloride bulk with DMF, WC offered by Cipla Limited

    Find a price of Apremilast bulk with DMF, WC offered by Cipla Limited

    Find a price of Arformoterol Tartrate bulk with DMF, WC offered by Cipla Limited

    Find a price of Atazanavir Sulfate bulk with DMF, WC offered by Cipla Limited

    Find a price of Bosentan Hydrate bulk with DMF, WC offered by Cipla Limited

    Find a price of Capecitabine bulk with WC offered by Cipla Limited

    Find a price of Ciclesonide bulk with CEP, WC offered by Cipla Limited

    Find a price of Cinacalcet Hydrochloride bulk with DMF, WC offered by Cipla Limited

    Find a price of Danazol bulk with DMF, WC offered by Cipla Limited

    Find a price of Darifenacin Hydrobromide bulk with DMF, WC offered by Cipla Limited

    Find a price of Darunavir Ethanolate bulk with DMF, WC offered by Cipla Limited

    Find a price of Deferasirox bulk with DMF, WC offered by Cipla Limited

    Find a price of Dolutegravir Sodium bulk with DMF, WC offered by Cipla Limited

    Find a price of Eliglustat bulk with DMF, WC offered by Cipla Limited

    Find a price of Empagliflozin bulk with DMF, WC offered by Cipla Limited

    Find a price of Emtricitabine bulk with DMF, WC offered by Cipla Limited

    Find a price of Entecavir bulk with DMF, CEP offered by Cipla Limited

    Find a price of Erlotinib Hydrochloride bulk with DMF, WC offered by Cipla Limited

    Find a price of Escitalopram Oxalate bulk with DMF, CEP offered by Cipla Limited

    Find a price of Famciclovir bulk with DMF, WC offered by Cipla Limited

    Find a price of Finasteride bulk with WC offered by Cipla Limited

    Find a price of Fluticasone Propionate bulk with DMF, CEP offered by Cipla Limited

    Find a price of Granisetron bulk with DMF, WC offered by Cipla Limited

    Find a price of Ipratropium Bromide bulk with WC offered by Cipla Limited

    Find a price of Irinotecan Hydrochloride bulk with WC offered by Cipla Limited

    Find a price of Lenalidomide bulk with DMF, WC offered by Cipla Limited

    Find a price of Levocetirizine Dihydrochloride bulk with DMF, WC offered by Cipla Limited

    Find a price of Mebendazole bulk with DMF, WC offered by Cipla Limited

    Find a price of Montelukast Sodium bulk with DMF, WC offered by Cipla Limited

    Find a price of Nintedanib Esylate bulk with DMF, WC offered by Cipla Limited

    Find a price of Olanzapine bulk with WC offered by Cipla Limited

    Find a price of Omeprazole Magnesium bulk with CEP, WC offered by Cipla Limited

    Find a price of Palonosetron bulk with DMF, WC offered by Cipla Limited

    Find a price of Pazopanib Hydrochloride bulk with DMF, WC offered by Cipla Limited

    Find a price of Ritonavir bulk with DMF, WC offered by Cipla Limited

    Find a price of Rivaroxaban bulk with DMF, CEP offered by Cipla Limited

    Find a price of Telmisartan bulk with DMF, WC offered by Cipla Limited

    Find a price of Tenofovir Disoproxil Fumarate bulk with DMF, WC offered by Cipla Limited

    Find a price of Tiotropium Bromide bulk with CEP, WC offered by Cipla Limited

    Find a price of Topiramate bulk with DMF, WC offered by Cipla Limited

    Find a price of Valacyclovir Hydrochloride bulk with DMF, WC offered by Cipla Limited

    Find a price of Valganciclovir Hydrochloride bulk with DMF, WC offered by Cipla Limited

    Find a price of Vinblastine Sulfate bulk with WC offered by Cipla Limited

    Find a price of Vincristine Sulfate bulk with WC offered by Cipla Limited

    Find a price of Vortioxetine Hydrobromide bulk with DMF, WC offered by Cipla Limited

    Find a price of Albendazole bulk with WC offered by Cipla Limited

    Find a price of Amlodipine Mesylate bulk with WC offered by Cipla Limited

    Find a price of Artemether bulk with WC offered by Cipla Limited

    Find a price of Artesunate bulk with WC offered by Cipla Limited

    Find a price of Carboplatin bulk with CEP offered by Cipla Limited

    Find a price of Citalopram Hydrobromide bulk with DMF offered by Cipla Limited

    Find a price of Citalopram Hydrobromide bulk with WC offered by Cipla Limited

    Find a price of Daclatasvir bulk with WC offered by Cipla Limited

    Find a price of Darunavir bulk with DMF offered by Cipla Limited

    Find a price of Donepezil bulk with WC offered by Cipla Limited

    Find a price of Efavirenz bulk with DMF offered by Cipla Limited

    Find a price of Flutamide bulk with WC offered by Cipla Limited

    Find a price of Lamivudine bulk with WC offered by Cipla Limited

    Find a price of Lansoprazole bulk with CEP offered by Cipla Limited

    Find a price of Levalbuterol Sulfate bulk with WC offered by Cipla Limited

    Find a price of Lopinavir bulk with DMF offered by Cipla Limited

    Find a price of Losartan Potassium bulk offered by Cipla Limited

    Find a price of Lumefantrine bulk with WC offered by Cipla Limited

    Find a price of Mometasone Furoate bulk with CEP offered by Cipla Limited

    Find a price of Nevirapine bulk with DMF offered by Cipla Limited

    Find a price of Oxaliplatin bulk with CEP offered by Cipla Limited

    Find a price of Paliperidone bulk with WC offered by Cipla Limited

    Find a price of Pregabalin bulk with WC offered by Cipla Limited

    Find a price of Salbutamol Sulphate bulk with CEP offered by Cipla Limited

    Find a price of Saxagliptin Hydrochloride bulk with WC offered by Cipla Limited

    Find a price of Sorafenib bulk with WC offered by Cipla Limited

    Find a price of Temozolomide bulk with WC offered by Cipla Limited

    Find a price of Tenofovir Disoproxil Fumarate bulk with DMF offered by Cipla Limited

    Find a price of Zidovudine bulk with DMF offered by Cipla Limited

    Find a price of Zoledronic Acid bulk with WC offered by Cipla Limited

    Find a price of Abiraterone Acetate bulk with DMF offered by Cipla Limited

    Find a price of Acalabrutinib bulk with DMF offered by Cipla Limited

    Find a price of Albendazole bulk with DMF offered by Cipla Limited

    Find a price of Alfuzosin HCl bulk offered by Cipla Limited

    Find a price of Alosetron Hydrochloride bulk with DMF offered by Cipla Limited

    Find a price of Ambrisentan bulk with WC offered by Cipla Limited

    Find a price of Amlodipine Besylate bulk with CEP offered by Cipla Limited

    Find a price of Apixaban bulk with DMF offered by Cipla Limited

    Find a price of Atazanavir Sulfate bulk with DMF offered by Cipla Limited

    Find a price of Azelastine Hydrochloride bulk offered by Cipla Limited

    Find a price of Beclomethasone Dipropionate bulk with DMF offered by Cipla Limited

    Find a price of Bictegravir Sodium bulk with DMF offered by Cipla Limited

    Find a price of Brexpiprazole bulk with DMF offered by Cipla Limited

    Find a price of Budesonide bulk with CEP offered by Cipla Limited

    Find a price of Cabotegravir bulk with DMF offered by Cipla Limited

    Find a price of Cabotegravir Sodium bulk with DMF offered by Cipla Limited

    Find a price of Cetirizine Dihydrochloride bulk with WC offered by Cipla Limited

    Find a price of Ciprofloxacin Hydrochloride bulk offered by Cipla Limited

    Find a price of Cisplatin bulk with CEP offered by Cipla Limited

    Find a price of Danazol bulk with WC offered by Cipla Limited

    Find a price of Dasatinib bulk with DMF offered by Cipla Limited

    Find a price of Deferiprone bulk with WC offered by Cipla Limited

    Find a price of Difelikefalin bulk with DMF offered by Cipla Limited

    Find a price of Disodium Pamidronate Pentahydrate bulk offered by Cipla Limited

    Find a price of Docetaxel bulk with WC offered by Cipla Limited

    Find a price of Dolutegravir Sodium bulk with DMF offered by Cipla Limited

    Find a price of Donepezil bulk with DMF offered by Cipla Limited

    Find a price of Dutasteride bulk offered by Cipla Limited

    Find a price of Edaravone bulk with DMF offered by Cipla Limited

    Find a price of Entecavir Monohydrate bulk with WC offered by Cipla Limited

    Find a price of Enzalutamide bulk with DMF offered by Cipla Limited

    Find a price of Fexofenadine Hydrochloride bulk offered by Cipla Limited

    Find a price of Fluconazole bulk with DMF offered by Cipla Limited

    Find a price of Fluticasone Furoate bulk with DMF offered by Cipla Limited

    Find a price of Fluticasone Propionate bulk with CEP offered by Cipla Limited

    Find a price of Gemcitabine bulk offered by Cipla Limited

    Find a price of Icatibant Acetate bulk with DMF offered by Cipla Limited

    Find a price of Imatinib Mesylate bulk offered by Cipla Limited

    Find a price of Indacaterol Acetate bulk with DMF offered by Cipla Limited

    Find a price of Isavuconazonium Sulfate bulk with DMF offered by Cipla Limited

    Find a price of Ivabradine Hydrochloride bulk with WC offered by Cipla Limited

    Find a price of Ivacaftor bulk with DMF offered by Cipla Limited

    Find a price of Lenalidomide bulk with DMF offered by Cipla Limited

    Find a price of Levalbuterol Hydrochloride bulk with DMF offered by Cipla Limited

    Find a price of Levalbuterol Tartrate bulk with WC offered by Cipla Limited

    Find a price of Levofloxacin bulk with DMF offered by Cipla Limited

    Find a price of Levofloxacin Hemihydrate bulk with WC offered by Cipla Limited

    Find a price of Levonorgestrel bulk with DMF offered by Cipla Limited

    Find a price of Linagliptin bulk with WC offered by Cipla Limited

    Find a price of Mirabegron bulk with DMF offered by Cipla Limited

    Find a price of Mitoxantrone bulk offered by Cipla Limited

    Find a price of Mometasone Furoate bulk with DMF offered by Cipla Limited

    Find a price of Nateglinide bulk offered by Cipla Limited

    Find a price of Nilotinib bulk with DMF offered by Cipla Limited

    Find a price of Nirmatrelvir bulk with DMF offered by Cipla Limited

    Find a price of Norfloxacin bulk offered by Cipla Limited

    Find a price of Olaparib bulk with DMF offered by Cipla Limited

    Find a price of Olmesartan Medoxomil bulk offered by Cipla Limited

    Find a price of Ondansetron bulk with WC offered by Cipla Limited

    Find a price of Oseltamivir Phosphate bulk with WC offered by Cipla Limited

    Find a price of Paclitaxel bulk with WC offered by Cipla Limited

    Find a price of Pemetrexed Disodium bulk with WC offered by Cipla Limited

    Find a price of Pioglitazone Hydrochloride bulk with DMF offered by Cipla Limited

    Find a price of Pomalidomide bulk with DMF offered by Cipla Limited

    Find a price of Praziquantel bulk with WC offered by Cipla Limited

    Find a price of Relugolix bulk with DMF offered by Cipla Limited

    Find a price of Revefenacin bulk with DMF offered by Cipla Limited

    Find a price of Rilpivirine bulk with DMF offered by Cipla Limited

    Find a price of Rilpivirine Hydrochloride bulk with DMF offered by Cipla Limited

    Find a price of Rizatriptan Benzoate bulk with DMF offered by Cipla Limited

    Find a price of Ruxolitinib Phosphate bulk with DMF offered by Cipla Limited

    Find a price of Salbutamol Sulphate bulk with DMF offered by Cipla Limited

    Find a price of Salmeterol Xinafoate bulk with DMF offered by Cipla Limited

    Find a price of Sertraline Hydrochloride bulk offered by Cipla Limited

    Find a price of Siponimod bulk with DMF offered by Cipla Limited

    Find a price of Sodium Thiosulfate bulk with DMF offered by Cipla Limited

    Find a price of Sorafenib bulk with DMF offered by Cipla Limited

    Find a price of Sumatriptan bulk offered by Cipla Limited

    Find a price of Tafamidis bulk with DMF offered by Cipla Limited

    Find a price of Tegafur bulk with WC offered by Cipla Limited

    Find a price of Tenofovir bulk with WC offered by Cipla Limited

    Find a price of Tenofovir Alafenamide Fumarate bulk with DMF offered by Cipla Limited

    Find a price of Ticagrelor bulk with WC offered by Cipla Limited

    Find a price of Tolterodine Tartrate bulk with DMF offered by Cipla Limited

    Find a price of Umeclidinium Bromide bulk with DMF offered by Cipla Limited

    Find a price of UNII-B7XF2TD73C bulk with WC offered by Cipla Limited

    Find a price of Vilanterol Trifenatate bulk with DMF offered by Cipla Limited

    Find a price of Vinorelbine Tartrate bulk offered by Cipla Limited

    Find a price of Zolpidem Tartrate bulk offered by Cipla Limited

    Find a price of OMEPRAZOLE USP PROCESS-II bulk with DMF offered by Cipla Limited

    Find a price of Aciclovir bulk offered by Cipla Limited

    Find a price of Adefovir Dipivoxil bulk offered by Cipla Limited

    Find a price of Alprazolam bulk offered by Cipla Limited

    Find a price of Androsterone bulk offered by Cipla Limited

    Find a price of Aripiprazole bulk offered by Cipla Limited

    Find a price of Bortezomib bulk offered by Cipla Limited

    Find a price of Celecoxib bulk offered by Cipla Limited

    Find a price of Clonidine bulk offered by Cipla Limited

    Find a price of Clopidogrel bulk offered by Cipla Limited

    Find a price of Darunavir bulk offered by Cipla Limited

    Find a price of Darunavir Ethanolate bulk offered by Cipla Limited

    Find a price of Desloratadine bulk offered by Cipla Limited

    Find a price of Didanosine bulk offered by Cipla Limited

    Find a price of Doxazosin Mesylate bulk offered by Cipla Limited

    Find a price of Drospirenone bulk offered by Cipla Limited

    Find a price of Emtricitabine bulk offered by Cipla Limited

    Find a price of Ibrutinib bulk offered by Cipla Limited

    Find a price of Ibuprofen bulk offered by Cipla Limited

    Find a price of Imiquimod bulk offered by Cipla Limited

    Find a price of Irbesartan bulk offered by Cipla Limited

    Find a price of Lamivudine bulk offered by Cipla Limited

    Find a price of Lorazepam bulk offered by Cipla Limited

    Find a price of Metaproterenol Hemisulfate bulk offered by Cipla Limited

    Find a price of Methocarbamol bulk offered by Cipla Limited

    Find a price of Metoprolol Tartrate bulk offered by Cipla Limited

    Find a price of Moxifloxacin Hydrochloride bulk offered by Cipla Limited

    Find a price of Mycophenolate Mofetil bulk offered by Cipla Limited

    Find a price of Nifedipine bulk offered by Cipla Limited

    Find a price of Ofloxacin bulk offered by Cipla Limited

    Find a price of Olanzapine bulk offered by Cipla Limited

    Find a price of Pantoprazole Sodium bulk offered by Cipla Limited

    Find a price of Pazopanib Hydrochloride bulk offered by Cipla Limited

    Find a price of Perindopril Erbumine bulk offered by Cipla Limited

    Find a price of Podophyllotoxin bulk offered by Cipla Limited

    Find a price of Pomalidomide bulk offered by Cipla Limited

    Find a price of Propranolol Hydrochloride bulk offered by Cipla Limited

    Find a price of Quetiapine Hemifumarate bulk offered by Cipla Limited

    Find a price of Rabeprazole Sodium bulk offered by Cipla Limited

    Find a price of Raloxifene Hydrochloride bulk offered by Cipla Limited

    Find a price of Ranolazine bulk offered by Cipla Limited

    Find a price of Rosiglitazone Maleate bulk offered by Cipla Limited

    Find a price of Salmeterol Xinafoate bulk offered by Cipla Limited

    Find a price of Sibutramine Hydrochloride bulk offered by Cipla Limited

    Find a price of Stavudine bulk offered by Cipla Limited

    Find a price of Tamsulosin bulk offered by Cipla Limited

    Find a price of Terbinafine Hydrochloride bulk offered by Cipla Limited

    Find a price of Terbutaline Sulfate bulk offered by Cipla Limited

    Find a price of Testosterone bulk offered by Cipla Limited

    Find a price of Topotecan Hydrochloride bulk offered by Cipla Limited

    Find a price of Torsemide bulk offered by Cipla Limited

    Find a price of Trioxsalen bulk offered by Cipla Limited

    Find a price of Zaleplon bulk offered by Cipla Limited

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN PATALGANGA, INDIA. bulk offered by Cipla Limited

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN KURKUMBH, INDIA. bulk offered by Cipla Limited

    Find a price of PROPANOLOL HCl bulk offered by Cipla Limited

    Find a price of FACILITIES, CONTROLS, AND OPERATING PROC. AT VIKHROLI, INDIA bulk offered by Cipla Limited

    Find a price of FACILITIES, CONTROLS AND OPERATING PROC. AT BOMBAY, INDIA bulk offered by Cipla Limited

    Find a price of FACILITIES, CONTROLS, AND OPERATING PROC. AT BANGALORE, INDIA bulk offered by Cipla Limited

    Find a price of Apalutamide bulk offered by Cipla Limited

    Find a price of Apremilast bulk offered by Cipla Limited

    Find a price of Axitinib bulk offered by Cipla Limited

    Find a price of Baricitinib bulk offered by Cipla Limited

    Find a price of Bictegravir bulk offered by Cipla Limited

    Find a price of CID 69349199 bulk offered by Cipla Limited

    Find a price of CID 9873495 bulk offered by Cipla Limited

    Find a price of Crisaborole bulk offered by Cipla Limited

    Find a price of Dexlansoprazole bulk offered by Cipla Limited

    Find a price of Everolimus bulk offered by Cipla Limited

    Find a price of Favipiravir bulk offered by Cipla Limited

    Find a price of Glatiramer Acetate bulk offered by Cipla Limited

    Find a price of Glycopyrronium Bromide bulk offered by Cipla Limited

    Find a price of Lenvatinib bulk offered by Cipla Limited

    Find a price of Lifitegrast bulk offered by Cipla Limited

    Find a price of Palbociclib bulk offered by Cipla Limited

    Find a price of Pioglitazone bulk offered by Cipla Limited

    Find a price of Ribociclib bulk offered by Cipla Limited

    Find a price of Sacubitril-Valsartan bulk offered by Cipla Limited

    Find a price of Sitagliptin Hydrochloride bulk offered by Cipla Limited

    Find a price of Sitagliptin Phosphate bulk offered by Cipla Limited

    Find a price of Sofosbuvir bulk offered by Cipla Limited

    Find a price of Sorafenib bulk offered by Cipla Limited

    Find a price of Sugammadex Sodium bulk offered by Cipla Limited

    Find a price of Valsartan bulk offered by Cipla Limited

    Find a price of Vildagliptin bulk offered by Cipla Limited

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search